Gene Information
Gene Name
|
PGR |
Gene ID
|
5241
|
Gene Full Name
|
progesterone receptor |
Gene Alias
|
PR; NR3C3 |
Transcripts
|
ENSG00000082175
|
Virus
|
HBV |
Gene Type
|
protein coding |
HPA Location Info
|
|
HPA Protein Class Info
|
Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors |
Gene Function
|
Suppressor gene
|
Uniport_ID
|
P06401
|
HGNC ID
|
HGNC:8910
|
VEGA ID
|
OTTHUMG00000167531
|
OMIM ID
|
607311 |
String ID
|
9606.ENSP00000325120
|
Drugbank ID
|
BE0000557
|
Drug (Cytoscape Annotation)
|
Dexamethasone |
PharmGKB ID
|
PA266
|
FDA Approved Drug
|
Anastrozole;Docetaxel;Eribulin;Exemestane;Fulvestrant;Goserelin;Ixabepilone;Lapatinib;Letrozole;Neratinib;Olaparib;Pertuzumab;Ribociclib;Tamoxifen;Trastuzumab |
Target gene [PGR] related to VISs
DVID |
Chromosome |
HM |
TFBS |
CA |
Sum of Overlapped Records |
Detail |
1010205 |
chr11 |
3 |
10 |
|
13 |
View |
1013024 |
chrX |
4 |
2 |
|
6 |
View |
Relationship between gene expression and immune infiltrating cell level
Data ID |
Disease |
Sample number |
Sample type |
LIHC (TCGA) |
Liver hepatocellular carcinoma |
424 |
Liver hepatocellular carcinoma HCV (HBV+)(86), Liver hepatocellular carcinoma HCV (HBV-)(19), Liver hepatocellular carcinoma (HBV+)(209), Liver hepatocellular carcinoma (HBV+)(60), Paracancerous HCV (HBV+)(4), Paracancerous (HBV-)(28), Paracancerous (HBV+)(18) |
> Dataset: LIHC
|
HeatMap of cell type fractions in all samples
|
Lollipop of PGR expression and immune infiltrating cell level correlation result in HBV+ samples
|
PGR expression: Low -> High
|
|
|
|
|